Prof. Richard Greil MD
Head of the IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria Prof. Rebecca Dent MD FRCP (Canada)
Chair, Divison of Medical Oncology & Senior Consultant, National Cancer Center Singapore
Professor, Duke-NUS Medical School, Singapore Dr. Denise Wolf PhD Senior Bioinformatics Scientist, Department of Laboratory Medicine, University of California, San Francisco, CA, USA Dr. Amrita Basu PhD
Assistant Professor, Department of Surgery, University of California, San Francisco, CA, USA Prof. Dr. Fritz Aberger
Molecular Cancer and Stem Cell Research, Lab Department of Molecular Biology, University of Salzburg, Cancer Cluster Salzburg (CCS), Salzburg, Austria Assoc. Prof. Gabriel Rinnerthaler MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria Luca Gianni MD
Chair, Breast Cancer Research Committee, Michelangelo Foundation, Milano, Italy Dr. Roberto Salgado Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium; Division of Research, Peter Mac Callum Cancer Center, Melbourne, Australia Prof. Pedro Romero MD Deputy scientific managing director of the Lausanne Branch of the Ludwig Institute for Cancer Research, Department of Oncology, University of Lausanne, Switzerland Prof. Alexander Egle MD
IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer, Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria Dr. Iosifina Foskolou Department of Haematopoiesis, Sanquin, Amsterdam, NL and
Department of Physiology, Development and Neuroscience, Cambridge University, UK
Prof. Dr. Barbara Seliger Director of the Institute for Medical Immunology, Martin Luther University, Medical Faculty, Halle, Germany
Prof. Laurence Zitvogel MD PhD Gustave Roussy Comprehensive Cancer Institute, Villejuif, France
Université Paris Saclay, Faculty of Medicine, Le Kremlin-Bicêtre, France, INSERM U1015, Villejuif, France Berna Özdemir MD PhD Department of Medical Oncology, Bern University Hospital and University of Bern, Switzerland
Priv.-Doz. Simon P. Gampenrieder MD IIIrd Medical Department, University Hospital Salzburg, Paracelsus Medical University, Salzburg Cancer Research Institute (SCRI), Cancer Cluster Salzburg (CCS), Salzburg, Austria
Prof. Giuseppe Curigliano MD PhD Professor of Medical Oncology, University of Milano, Head of Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy
Prof. Dr. Niels Schaft PhD
Research group leader of the RNA-based Immunotherapy group, Department of Dermatology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
finalProgramme
Friday, 21. October 2022
12:30 – 13:30 Welcome & Business Lunch
13:30 – 13:35 Introduction Richard Greil, Salzburg
13:35 – 15:30 Clinical and Translational research Chair: Richard Greil, Denise M. Wolf
Current evidence of immunotherapy in early breast cancer Rebecca Dent (Singapore)
Predictive biomarkers for immunotherapy – findings from the I-SPY 2 trial Denise M. Wolf (California) Predictive factors for immune-related side effects Amrita Basu (California)
Panel-Discussion All speakers
Moderator: Richard Greil (Salzburg)
15:30 – 16:00 Coffee Break
16:00 – 18:30 Innate and adaptive Immune system Chair: Fritz Aberger, Gabriel Rinnerthaler
Single-Cell spatial immune cell composition – findings from the NeoTRIPaPDL1 trial Luca Gianni (Milano)
PD-L1 vs. TILs: analytic and diagnostic issues Roberto Salgado (Antwerp)
Harnessing metabolic pathways to enhance antitumor immunity and immunotherapy Pedro Romero (Lausanne)
Panel-Discussion All speakers
Moderator: Richard Greil (Salzburg)
Saturday, 22. October 2022
08:30 – 11:00 Metabolism & Immunogenicity Chair: Pedro Romero, Alexander Egle
Hypoxia-inducible metabolites shape T cell fate Iosifina Foskolou (Cambridge)
Immune escape in breast cancer and its therapeutic relevance Barbara Seliger (Halle)
Influence on immunogenicity by the microbioma Laurence Zitvogel (Paris)
Influence on immunogenicity by sex hormones Berna C. Özdemir (Lausanne)
Panel-Discussion (focusing on immunogenicity) All speakers Moderator: Richard Greil (Salzburg)
11:00 – 11:30 Coffee break
11:30 – 13:00 New treatment strategies Chair: Simon Gampenrieder, Niels Schaft Immunotherapy strategies beyond PD1/PD-L1 inhibition Giuseppe Curigliano (Milano)
CAR T-Cells in breast cancer
Niels Schaft (Erlangen) Panel discussion All speakers Moderator: Richard Greil (Salzburg)
Closing Remarks Richard Greil (Salzburg)
13:00 – 14:00 Business Lunch & Farewell
Registration
The registration form is now available, we look forward to your submission. We would like to point out that this conference is not open to the public. After your registration your entries will be checked by us, followed by information about your requested participation.
Accreditation by ÖÄK
4th SALZBURG BREAST CANCER TALK – Mastering translational Immuno-Oncology has been accredited by the Diploma Continuing Education Program of the Austrian Medical Association (ÖÄK) for a maximum of 11 DFP points.
v.l.n.r. R. Salgado (blaues Hemd), N. Schaft (dahinter), I. Foskolou (2.Reihe), R. Greil, P. Romero, S. Gampenrieder, D. Wolf, G. Rinnerthaler (dahinter), A. Basu
POSTPONED DUE TO SARS-CoV-2 Due to the current situation concerning the coronavirus epidemic and the resulting travel restrictions of even already planned speakers, we have decided to reschedule our event „Salzburg Breast Cancer Talk“ to October 2022....
Die Veranstaltung 3rd SALZBURG BREAST CANCER TALK, MASTERING TRANSLATIONAL IMMUNO-ONCOLOGY vom 01. bis 02.03.2019, im PITTER Event Center Salzburg war mit über 100 Teilnehmern wieder ein voller Erfolg. Die Vortragenden, alle auf ihrem Fachgebiet international renommierte Wissenschaftler, verstanden es eindrucksvoll, dem fachkundigen Publikum Einblicke in ihre Forschung am Puls der Zeit zu gewähren. Die Disskusionsrunden […]...
Wir verwenden Cookies, um Ihr Erlebnis auf unserer Website so angenehm wie möglich zu gestalten, um Inhalte und Anzeigen zu personalisieren, Funktionen für soziale Medien anbieten zu können und die Zugriffe auf unsere Website zu analysieren. Außerdem geben wir Informationen zu Ihrer Verwendung unserer Website an unsere Partner für soziale Medien, Werbung und Analysen weiter. Unsere Partner führen diese Informationen möglicherweise mit weiteren Daten zusammen, die Sie ihnen bereitgestellt haben oder die sie im Rahmen Ihrer Nutzung der Dienste gesammelt haben. Mit der weiteren Nutzung der Seite geben Sie die Einwilligung zu unseren Cookies. Weitere Informationen über unsere Datenerfassungspraktiken finden Sie in unserer Datenschutzerklärung.OKABLEHNENDatenschutzerklärung